Masaki Hatano

671 total citations
35 papers, 469 citations indexed

About

Masaki Hatano is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Masaki Hatano has authored 35 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 18 papers in Pharmacology and 7 papers in Organic Chemistry. Recurrent topics in Masaki Hatano's work include Microbial Natural Products and Biosynthesis (17 papers), Synthetic Organic Chemistry Methods (5 papers) and Plant-Microbe Interactions and Immunity (3 papers). Masaki Hatano is often cited by papers focused on Microbial Natural Products and Biosynthesis (17 papers), Synthetic Organic Chemistry Methods (5 papers) and Plant-Microbe Interactions and Immunity (3 papers). Masaki Hatano collaborates with scholars based in Japan, South Korea and Indonesia. Masaki Hatano's co-authors include Masayuki Igarashi, Ryûichi Sawa, Maya Umekita, Chigusa Hayashi, Akio Nomoto, Yumiko Kubota, Naoko Kinoshita, Chiaki Kato, Shun‐ichi Wada and Shinichi Nishimura and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Bacteriology.

In The Last Decade

Masaki Hatano

34 papers receiving 461 citations

Peers

Masaki Hatano

PHARM

BIOTE

Soohyun Um South Korea

Eva Mösker Germany

Katharine R. Watts United States

Juan E. Velásquez United States

Hui Hong United Kingdom

Sascha Baumann Germany

Michael Winn United Kingdom

Christopher D. Fage Germany

Si‐Kyu Lim United States

Nadia Kadi United Kingdom

Soohyun Um South Korea

Masaki Hatano

293 ×1.3

292 ×1.6

PHARM

101 ×1.0

156 ×1.6

BIOTE

64 ×1.1

Citations per year, relative to Masaki Hatano Masaki Hatano (= 1×) peers Soohyun Um

Countries citing papers authored by Masaki Hatano

Since Specialization

Citations

This map shows the geographic impact of Masaki Hatano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaki Hatano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaki Hatano more than expected).

Fields of papers citing papers by Masaki Hatano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masaki Hatano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaki Hatano. The network helps show where Masaki Hatano may publish in the future.

Co-authorship network of co-authors of Masaki Hatano

This figure shows the co-authorship network connecting the top 25 collaborators of Masaki Hatano. A scholar is included among the top collaborators of Masaki Hatano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masaki Hatano. Masaki Hatano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nukui, Seiji, et al.. (2025). Study about fluostatins: efficient preparation of fluostatin A and discovery of fluostatin derivatives from Streptomyces sp. TA-3391. The Journal of Antibiotics. 78(9). 552–559.

Ishizaki, Yoshimasa, Maya Umekita, Masaki Hatano, et al.. (2023). Cycloimidamicins, Novel natural lead compounds for translation inhibition in Pseudomonas aeruginosa. The Journal of Antibiotics. 76(12). 691–698. 1 indexed citations

Kimura, Tomoyuki, Maya Umekita, Masaki Hatano, et al.. (2022). Wychimicins, a new class of spirotetronate polyketides from Actinocrispum wychmicini MI503-A4. The Journal of Antibiotics. 75(10). 535–541. 4 indexed citations

Kawada, Manabu, Hideyuki Muramatsu, Masaki Hatano, et al.. (2021). The potent protein phosphatase 2A inhibitors aminocytostatins: new derivatives of cytostatin. The Journal of Antibiotics. 74(10). 743–751. 3 indexed citations

Ishida, Takashi, Takumi Higaki, Takashi Ideue, et al.. (2021). Discovery, characterization and functional improvement of kumamonamide as a novel plant growth inhibitor that disturbs plant microtubules. Scientific Reports. 11(1). 6077–6077. 4 indexed citations

Hashizume, Hideki, Ryûichi Sawa, Kiyoko Iijima, et al.. (2020). New chloptosins B and C from an Embleya strain exhibit synergistic activity against methicillin-resistant Staphylococcus aureus when combined with co-producing compound L-156,602. The Journal of Antibiotics. 74(1). 80–85. 6 indexed citations

Kim, Taejung, Young‐Tae Park, Masayuki Igarashi, et al.. (2019). Total Synthesis of Pactalactam, an Imidazolidinone-Type Pactamycin Analogue. Organic Letters. 21(10). 3554–3557. 9 indexed citations

Iijima, Masatomi, Yuji Kubota, Ryûichi Sawa, et al.. (2017). A guanine derivative as a new MEK inhibitor produced by Streptomyces sp. MK63-43F2. The Journal of Antibiotics. 71(1). 135–138. 5 indexed citations

Igarashi, Masayuki, Ryûichi Sawa, M. Yamasaki, et al.. (2017). Kribellosides, novel RNA 5′-triphosphatase inhibitors from the rare actinomycete Kribbella sp. MI481-42F6. The Journal of Antibiotics. 70(5). 582–589. 24 indexed citations

10.

Umekita, Maya, et al.. (2017). Fradiamine A, a new siderophore from the deep-sea actinomycete Streptomyces fradiae MM456M-mF7. The Journal of Antibiotics. 70(5). 611–615. 24 indexed citations

11.

Wada, Shun‐ichi, Ryûichi Sawa, Yumiko Kubota, et al.. (2017). Structures and biological activities of novel 4’-acetylated analogs of chrysomycins A and B. The Journal of Antibiotics. 70(11). 1078–1082. 13 indexed citations

12.

Nakasone, Kaoru, Sho Okamoto, Masaki Hatano, et al.. (2016). Identification of the Three Genes Involved in Controlling Production of a Phytotoxin Tropolone in Burkholderia plantarii. Journal of Bacteriology. 198(11). 1604–1609. 11 indexed citations

13.

Wada, Shun‐ichi, Yumiko Kubota, Ryûichi Sawa, et al.. (2015). Novel autophagy inducers lentztrehaloses A, B and C. The Journal of Antibiotics. 68(8). 521–529. 15 indexed citations

14.

Ozeki, Yuriko, Masayuki Igarashi, Matsumi Doe, et al.. (2015). A New Screen for Tuberculosis Drug Candidates Utilizing a Luciferase-Expressing Recombinant Mycobacterium bovis Bacillus Calmette-Guéren. PLoS ONE. 10(11). e0141658–e0141658. 11 indexed citations

15.

Yamazaki, Yohko, Tetsuya Someno, Masayuki Igarashi, et al.. (2014). Androprostamines A and B, the new anti-prostate cancer agents produced by Streptomyces sp. MK932-CF8. The Journal of Antibiotics. 68(4). 279–285. 9 indexed citations

16.

Igarashi, Masayuki, Maya Umekita, Masaki Hatano, et al.. (2013). Waldiomycin, a novel WalK-histidine kinase inhibitor from Streptomyces sp. MK844-mF10. The Journal of Antibiotics. 66(8). 459–464. 41 indexed citations

17.

Nakae, Koichi, Fukiko Kojima, Masayuki Igarashi, et al.. (2013). Sacchathridine A, a Prostaglandin Release Inhibitor from Saccharothrix sp.. Journal of Natural Products. 76(4). 720–722. 9 indexed citations

18.

Kawada, Manabu, Hiroyuki Inoue, Shun‐ichi Ohba, et al.. (2013). Intervenolin, a new antitumor compound with anti-Helicobacter pylori activity, from Nocardia sp. ML96-86F2. The Journal of Antibiotics. 66(9). 543–548. 26 indexed citations

19.

Iinuma, Hironobu, Yoko Ikeda, Masayuki Igarashi, et al.. (2012). Migracins A and B, new inhibitors of cancer cell migration, produced by Streptomyces sp.. The Journal of Antibiotics. 66(4). 225–230. 13 indexed citations

20.

Igarashi, Masayuki, Toshihide Okajima, Eiji Ishii, et al.. (2012). Isolation and Characterization of Signermycin B, an Antibiotic That Targets the Dimerization Domain of Histidine Kinase WalK. Antimicrobial Agents and Chemotherapy. 56(7). 3657–3663. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact